We are live on ! Find out more
CVS icon

CVS Health

1,236 hedge funds and large institutions have $74.9B invested in CVS Health in 2014 Q1 according to their latest regulatory filings, with 94 funds opening new positions, 497 increasing their positions, 503 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 56

5% more capital invested

Capital invested by funds: $71.4B → $74.9B (+$3.57B)

3% more funds holding in top 10

Funds holding in top 10: 137141 (+4)

2% more funds holding

Funds holding: 1,2121,236 (+24)

7% more call options, than puts

Call options by funds: $241M | Put options by funds: $225M

0.38% more ownership

Funds ownership: 83.95%84.33% (+0.38%)

1% less repeat investments, than reductions

Existing positions increased: 497 | Existing positions reduced: 503

Holders
1,236
Holders Change
+24
Holders Change %
+1.98%
% of All Funds
35.68%
Holding in Top 10
141
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+2.92%
% of All Funds
4.07%
New
94
Increased
497
Reduced
503
Closed
56
Calls
$241M
Puts
$225M
Net Calls
+$15.4M
Net Calls Change
-$13.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Lord, Abbett & Co
251
Lord, Abbett & Co
New Jersey
$25.4M -$9.87M -139,663 -29%
HNB
252
Huntington National Bank
Ohio
$25.2M +$2.17M +30,667 +10%
MI
253
Markston International
New York
$25.1M -$63.6K -900 -0.3%
GIBU
254
Gulf International Bank (UK)
United Kingdom
$25M -$514K -7,273 -2%
AIM
255
Avity Investment Management
Connecticut
$24.8M -$713K -10,095 -3%
ASRS
256
Arizona State Retirement System
Arizona
$24.7M -$763K -10,800 -3%
NIM
257
Northeast Investment Management
Massachusetts
$24.4M -$621K -8,791 -3%
HIMCH
258
Hartford Investment Management Co (HIMCO)
Connecticut
$24.2M -$651K -9,214 -3%
LG
259
Leuthold Group
Minnesota
$24M -$288K -4,081 -1%
FLPIM
260
F.L. Putnam Investment Management
Massachusetts
$24M -$202K -2,860 -0.9%
SCA
261
STALEY CAPITAL ADVISERS
Pennsylvania
$24M +$12.3K +174 +0.1%
IRF
262
IBM Retirement Fund
New York
$23.6M -$12.3M -173,671 -35%
ADEF
263
Adams Diversified Equity Fund
Maryland
$23.5M
MC
264
Martin Currie
United Kingdom
$23.5M -$1.48M -21,006 -6%
EIM
265
ExxonMobil Investment Management
Texas
$23.2M -$11.9K -168 -0.1%
SFM
266
Systematic Financial Management
New Jersey
$23M -$25M -354,333 -54%
Citadel Advisors
267
Citadel Advisors
Florida
$23M +$1.64M +23,221 +8%
ICM
268
ICC Capital Management
Florida
$23M -$2.61M -36,925 -11%
CIM
269
Calvert Investment Management
Maryland
$22.8M -$12.3M -174,776 -36%
PA
270
Pinnacle Associates
New York
$22.6M +$283K +4,000 +1%
OI
271
Oakbrook Investments
Illinois
$22.2M -$7.36M -104,236 -26%
Nomura Asset Management
272
Nomura Asset Management
Japan
$22.2M +$3.5M +49,612 +20%
Barrow, Hanley, Mewhinney & Strauss
273
Barrow, Hanley, Mewhinney & Strauss
Texas
$22M -$4.71M -66,700 -18%
CIA
274
CCM Investment Advisers
South Carolina
$22M -$843K -11,930 -4%
IC
275
Inverness Counsel
New York
$21.8M -$1.19M -16,861 -5%

CVS Hedge Fund Activity: Q1 2014 in Review

1,236 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2014, worth a combined $74.9B — up 5% from $71.4B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new CVS positions and 56 closed out — a net gain of 38 holders — while 497 added to existing stakes and 503 trimmed.

The largest buyer was Vanguard Group, adding an estimated $631M. The largest seller was Davis Selected Advisers, cutting an estimated $1.53B.

  • 1,236 institutional investors held CVS Health (CVS) as of Q1 2014, up from 1,212 in Q4 2013.
  • Funds reported $74.9B of CVS Health stock for Q1 2014, up 5% quarter-over-quarter.
  • 94 funds opened new CVS Health positions in Q1 2014 and 56 closed out, a net change of +38 holders.
  • The largest CVS Health buyer in Q1 2014 was Vanguard Group, an estimated $631M added.
  • The largest CVS Health seller in Q1 2014 was Davis Selected Advisers, an estimated $1.53B sold.

Based on aggregated 13F filings for Q1 2014.